News J&J's Ebola vaccine approved in EU The European Commission has approved Johnson & Johnson's Ebola vaccine, developed by its Janssen pharmaceuticals unit and Bavarian Nordic.
News GSK sells travel vaccines to Bavarian Nordic GlaxoSmithKline (GSK) has sold off two travel vaccines to Bavarian Nordic, as the company shifts its focus away from drugs it acquired through a multi-billion “asset swap” deal with Novarti
News Janssen and Bavarian Nordic sign $836m deal on Hep B and HIV... Janssen has signed a new deal with Bavarian Nordic worth up to $836 million to develop target vaccines for hepatitis B and HIV.
News BMS looks to Opdivo + vaccine combo for non-PD-L1 lung cance... Bristol-Myers Squibb is teaming up with France’s Transgene to combine Opdivo with investigational therapeutic vaccine TG4010 in lung cancer.
